|
1.
|
Rock E and DeMichele A: Nutritional
approaches to late toxicities of adjuvant chemotherapy in breast
cancer survivors. J Nutr. 133:3785S–3793S. 2003.PubMed/NCBI
|
|
2.
|
Billingham ME, Mason JW, Bristow MR and
Daniels JR: Anthracycline cardiomyopathy monitored by morphologic
changes. Cancer Treat Rep. 62:865–872. 1978.PubMed/NCBI
|
|
3.
|
Bristow MR, Thompson PD, Martin RP, Mason
JW, Billingham ME and Harrison DC: Early anthracycline
cardiotoxicity. Am J Med. 65:823–832. 1978. View Article : Google Scholar
|
|
4.
|
Chicco AJ, Schneider CM and Hayward R:
Voluntary exercise protects against acute doxorubicin
cardiotoxicity in the isolated perfused rat heart. Am J Physiol
Regul Integr Comp Physiol. 289:R424–R431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Chicco AJ, Schneider CM and Hayward R:
Exercise training attenuates acute doxorubicin-induced cardiac
dysfunction. J Cardiovasc Pharmacol. 47:182–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hydock DS, Lien CY, Schneider CM and
Hayward R: Exercise preconditioning protects against
doxorubicin-induced cardiac dysfunction. Med Sci Sports Exerc.
40:808–817. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Albini A, Pennesi G, Donatelli F,
Cammarota R, De Flora S and Noonan DM: Cardiotoxicity of anticancer
drugs: the need for cardio-oncology and cardio-oncological
prevention. J Natl Cancer Inst. 102:14–25. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lissoni P: Biochemotherapy with
immunomodulating pineal hormones other than melatonin:
5-methoxytryptamine as a new oncostatic pineal agent. Pathol Biol
(Paris). 55:198–200. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Jawed S, Kim B, Ottenhof T, Brown GM,
Werstiuk ES and Niles LP: Human melatonin MT1 receptor induction by
valproic acid and its effects in combination with melatonin on
MCF-7 breast cancer cell proliferation. Eur J Pharmacol. 560:17–22.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Lemus-Wilson A, Kelly PA and Blask DE:
Melatonin blocks the stimulation effects of prolactin and human
breast cancer cell growth in culture. Br J Cancer. 72:1435–1440.
1995. View Article : Google Scholar
|
|
11.
|
Sánchez-Barceló EJ, Cos S, Mediavilla D,
Martínez-Campa C, González A and Alonso-González C:
Melatonin-estrogen interactions in breast cancer. J Pineal Res.
38:217–222. 2005.
|
|
12.
|
Zhang Y, Zhu S and Liu J: The reverse
effect and mechanism of melatonin on breast carcinoma cell line
MCF-7/ADM resistant to Adriamycin. Chinese Journal of Clinical
Oncology. 36:291–295. 2009.(In Chinese).
|
|
13.
|
Zhang Y, Zhu S and Zhao W: The effect of
melatonin on the sensitivity of ER+breast carcinoma cell
line MCF-7 to Adriamycin and its mechanism. Chinese Journal of
Clinical Oncology. 36:1243–1247. 2009.(In Chinese).
|
|
14.
|
Reiter RJ, Tan DX, Manchester LC, Paredes
SD, Mayo JC and Sainz RM: Melatonin and reproduction revisited.
Biol Reprod. 81:445–456. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Sener G, Jahovic N, Tosun O, Atasoy BM and
Yeğen BC: Melatonin ameliorates ionizing radiation-induced
oxidative organ damage in rats. Life Sci. 74:563–572. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Reiter RJ, Guerrero JM, Escames G,
Pappolla MA and Acuña-Castroviejo D: Prophylactic actions of
melatonin in oxidative neurotoxicity. Ann N Y Acad Sci. 825:70–78.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Okatani Y, Wakatsuki A and Kaneda C:
Melatonin increases activities of glutathione peroxidase and
superoxide dismutase in fetal rat brain. J Pineal Res. 28:89–96.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Reiter RJ, Acuña-Castroviejo D, Tan DX and
Burkhardt S: Free radical-mediated molecular damage. Mechanisms for
the protective actions of melatonin in the central nervous system.
Ann N Y Acad Sci. 939:200–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hardeland R, Pandi-Perumal SR and
Cardinali DP: Melatonin. Int J Biochem Cell Biol. 38:313–316. 2006.
View Article : Google Scholar
|
|
20.
|
Ganguly K, Kundu P, Banerjee A, Reiter RJ
and Swarnakar S: Hydrogen peroxide-mediated downregulation of
matrix metalloprotease-2 in indomethacin-induced acute gastric
ulceration is blocked by melatonin and other antioxidants. Free
Radic Biol Med. 41:911–925. 2006. View Article : Google Scholar
|
|
21.
|
Bruck R, Aeed H, Avni Y, et al: Melatonin
inhibits nuclear factor kappa B activation and oxidative stress and
protects against thioacetamide induced liver damage in rats. J
Hepatol. 40:86–93. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yurtcu E, Guney Y, Ergun MA, et al: Lack
of a time-dependent effect of melatonin on radiation-induced
apoptosis in cultured rat lymphocytes. Cell Biol Int. 31:1144–1149.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Russo J, Tay LK and Russo IH:
Differentiation of the mammary gland and susceptibility to
carcinogenesis. Breast Cancer Res Treat. 2:5–73. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Dagar S, Sekosan M, Rubinstein I and
Onyüksel H: Detection of VIP receptors in MNU-induced breast cancer
in rats: implications for breast cancer targeting. Breast Cancer
Res Treat. 65:49–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Sener-Muratoğlu G, Paskaloğlu K, Arbak S,
Hürdağ C and Ayanoğlu-Dülger G: Protective effect of famotidine,
omeprazole, and melatonin against acetylsalicylic acid-induced
gastric damage in rats. Dig Dis Sci. 46:318–330. 2001.PubMed/NCBI
|
|
26.
|
Maestroni GJ: The immunotherapeutic
potential of melatonin. Expert Opin Investig Drugs. 10:467–476.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wang WZ, Fang XH, Stephenson LL, et al:
Microcirculatory effects of melatonin in rat skeletal muscle after
prolonged ischemia. J Pineal Res. 39:57–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Topal T, Oter S, Korkmaz A, et al:
Exogenously administered and endogenously produced melatonin reduce
hyperbaric oxygen-induced oxidative stress in rat lung. Life Sci.
75:461–467. 2004. View Article : Google Scholar
|
|
29.
|
Fisher PW, Salloum F, Das A, et al:
Phosphodiesterase-5 inhibition with sildenafil attenuates
cardiomyocyte apoptosis and left ventricular dysfunction in a
chronic model of doxorubicin cardiotoxicity. Circulation.
111:1601–1610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Floyd JD, Nguyen DT, Lobins RL, et al:
Cardiotoxicity of cancer therapy. J Clin Oncol. 23:7685–7696. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Mirunalini S, Karthishwaran K, Dhamodharan
G and Shalini M: Melatonin attenuates lipid peroxidation and
enhances circulatory antioxidants during mammary carcinogenesis in
rats. J Biochem Tech. 2:171–174. 2010.
|
|
32.
|
Reiter RJ and Tan DX: Melatonin: a novel
protective agent against oxidative injury of the
ischemic/reperfused heart. Cardiovasc Res. 58:10–19. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Lissoni P, Barni S, Mandalá M, Ardizzoia
A, Paolorossi F, et al: Decreased toxicity and increased efficacy
of cancer chemotherapy using the pineal hormone melatonin in
metastatic solid tumour patients with poor clinical status. Eur J
Cancer. 35:1688–1692. 1999. View Article : Google Scholar
|
|
34.
|
Sánchez-Suárez P, Ostrosky-Wegman P,
Gallegos-Hernández F, et al: DNA damage in peripheral blood
lymphocytes in patients during combined chemotherapy for breast
cancer. Mutat Res. 640:8–15. 2008.PubMed/NCBI
|
|
35.
|
Lissoni P: Biochemotherapy with standard
chemotherapies plus the pineal hormone melatonin in the treatment
of advanced solid neoplasms. Pathol Biol (Paris). 55:201–204. 2007.
View Article : Google Scholar : PubMed/NCBI
|
